BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33852424)

  • 1. MECHANISMS IN ENDOCRINOLOGY: Paracrine and endocrine control of the growth hormone axis by estrogen.
    Birzniece V; Ho KKY
    Eur J Endocrinol; 2021 May; 184(6):R269-R278. PubMed ID: 33852424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paracrine regulation of growth hormone secretion by estrogen in women.
    Birzniece V; Sata A; Sutanto S; Ho KK
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3771-6. PubMed ID: 20444909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex steroids and the GH axis: Implications for the management of hypopituitarism.
    Birzniece V; Ho KKY
    Best Pract Res Clin Endocrinol Metab; 2017 Feb; 31(1):59-69. PubMed ID: 28477733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparate Effect of Aromatization on the Central Regulation of GH Secretion by Estrogens in Men and Postmenopausal Women.
    Birzniece V; McLean M; Reddy N; Ho KKY
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2978-2984. PubMed ID: 30920620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
    Weissberger AJ; Ho KK; Lazarus L
    J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing Estrogen Therapy in the Pituitary Patient.
    Shoung N; Ho KKY
    J Endocr Soc; 2023 Mar; 7(5):bvad051. PubMed ID: 37143694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of growth hormone action by sex steroids.
    Meinhardt UJ; Ho KK
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):413-22. PubMed ID: 16984231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Route-dependent endocrine and metabolic effects of estrogen replacement therapy.
    O'Sullivan AJ; Ho KK
    J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1457-66. PubMed ID: 11202222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic effects of oestrogens: impact of the route of administration.
    Ho KK; O'Sullivan AJ; Wolthers T; Leung KC
    Ann Endocrinol (Paris); 2003 Apr; 64(2):170-7. PubMed ID: 12773957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of leptin by metabolic state and its regulatory interactions with pituitary growth hormone and hepatic growth hormone receptors and insulin like growth factors in the tilapia (Oreochromis mossambicus).
    Douros JD; Baltzegar DA; Mankiewicz J; Taylor J; Yamaguchi Y; Lerner DT; Seale AP; Grau EG; Breves JP; Borski RJ
    Gen Comp Endocrinol; 2017 Jan; 240():227-237. PubMed ID: 27449341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex steroids, growth hormone, insulin-like growth factor-1: neuroendocrine and metabolic regulation in puberty.
    Mauras N; Rogol AD; Haymond MW; Veldhuis JD
    Horm Res; 1996; 45(1-2):74-80. PubMed ID: 8742123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement.
    Span JP; Pieters GF; Sweep CG; Hermus AR; Smals AG
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
    Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of dose and route of estrogen administration on the somatotropic axis in normal women.
    Lissett CA; Shalet SM
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4668-72. PubMed ID: 14557438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of endocrine disrupters on the expression of growth hormone and prolactin mRNA in the rainbow trout pituitary.
    Elango A; Shepherd B; Chen TT
    Gen Comp Endocrinol; 2006 Jan; 145(2):116-27. PubMed ID: 16188257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmentally relevant concentrations of 17alpha-ethinylestradiol (EE2) interfere with the growth hormone (GH)/insulin-like growth factor (IGF)-I system in developing bony fish.
    Shved N; Berishvili G; Baroiller JF; Segner H; Reinecke M
    Toxicol Sci; 2008 Nov; 106(1):93-102. PubMed ID: 18660547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogens regulate the hepatic effects of growth hormone, a hormonal interplay with multiple fates.
    Fernández-Pérez L; Guerra B; Díaz-Chico JC; Flores-Morales A
    Front Endocrinol (Lausanne); 2013; 4():66. PubMed ID: 23761784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A summary of the influence of exogenous estrogen administration across the lifespan on the GH/IGF-1 axis and implications for bone health.
    Southmayd EA; De Souza MJ
    Growth Horm IGF Res; 2017 Feb; 32():2-13. PubMed ID: 27693042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The influence of estrogen and progestogen replacement on growth hormone activity in women with hypopituitarism].
    Isotton AL; Wender MC; Czepielewski MA
    Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):901-16. PubMed ID: 18797598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex steroid regulation of growth hormone secretion and action.
    Ho KK; O'Sullivan AJ; Weissberger AJ; Kelly JJ
    Horm Res; 1996; 45(1-2):67-73. PubMed ID: 8742122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.